Atp13A3 And Caveolin-1 As Potential Biomarkers For Difluoromethylornithine-Based Therapies In Pancreatic Cancers
Keywords
ATP13A3; Difluoromethylornithine (DFMO); Pancreatic cancer; Polyamine transport; Polyamines
Abstract
The purpose of this paper was to better understand the role of polyamine transport in pancreatic cancers.This paper identifies potential biomarkers for assessing the relative tumor commitment to polyamine biosynthesis or transport. Cell lines with low polyamine import activity and low ATP13A3 protein levels appear committed to polyamine biosynthesis and required high concentrations of the polyamine biosynthesis inhibitor, difluoromethylornithine (DFMO) to inhibit their growth (e.g., AsPC-1 and Capan 1). In contrast, cell lines with high polyamine import activity and high ATP13A3 protein expression (e.g., L3.6pl) demonstrated a commitment to polyamine transport and required lower DFMO concentrations to inhibit their growth. Pancreatic cancer cell lines which were most sensitive to DFMO also gave the highest EC50 values for the polyamine transport inhibitors (PTIs) tested indicating that more PTI was needed to inhibit the active polyamine transport systems of these cell lines. Most significant is that the combination therapy of DFMO+PTI was efficacious against both cell types with the PTI showing low efficacy in cell lines with low polyamine transport activity and high efficacy in cell lines with high polyamine transport activity. High ATP13A3 protein expression and moderate to low Cav-1 protein expression was shown to be predictive of tumors which effectively escape DFMO via polyamine import. In summary, this report demonstrates for the first time the role of ATP13A3 in polyamine transport and its use as a potential biomarker along with Cav-1 to select tumors most susceptible to DFMO. These findings may help stratify patients in the ongoing clinical trials with DFMO-based therapies and help predict tumor response.
Publication Date
1-1-2016
Publication Title
American Journal of Cancer Research
Volume
6
Issue
6
Number of Pages
1231-1252
Document Type
Article
Personal Identifier
scopus
Copyright Status
Unknown
Socpus ID
85006213863 (Scopus)
Source API URL
https://api.elsevier.com/content/abstract/scopus_id/85006213863
STARS Citation
Madan, Meenu; Patel, Arjun; Skruber, Kristen; Geerts, Dirk; and Altomare, Deborah A., "Atp13A3 And Caveolin-1 As Potential Biomarkers For Difluoromethylornithine-Based Therapies In Pancreatic Cancers" (2016). Scopus Export 2015-2019. 2618.
https://stars.library.ucf.edu/scopus2015/2618